Summer Special! Get NewsNow Essentials at just £3.49 a month (12% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £3.49 a month (12% OFF!). Subscribe and saveSummer Special! Upgrade here at £3.49/m (12% OFF!)

Home
Hot Topics
Nigeria
Politics
Crime
Premier League
Economy
Africa
World
Entertainment
Sport
La Liga
Serie A
Bundesliga
Lifestyle
Bitcoin
Cryptocurrencies
Sensational News

AstraZeneca
Covid
Topics

Advertisement

AstraZeneca

Share

Top Latest Popular

Bristol-Myers stock: why AstraZeneca merger is unlikely to happen

Invezz 12h

Jim cramer senses a 'Fake out' in rumored AstraZeneca, Bristol Myers Squibb $400 billion mega-merger

Benzinga 15h

AstraZeneca and Bristol-Myers Squibb: Megamerger reports leave us scratching our heads

MorningStar.com 12h

Advertisement

Advertisement

Why did AstraZeneca shares fall 6% after Bristol Myers Squibb merger reports?

Invezz 19h

Analysts baffled by AstraZeneca's interest in Bristol Myers Squibb

Proactive Investors (US) 16h

Are we about to see a return for the pharma mega-merger?

pharmaphorum 19h

AstraZeneca investors balk at $400bn Bristol Myers tie-up reports

Gulf Times 10h

AstraZeneca-Bristol Myers merger buzz puts patent expiration and deal economics in focus

Benzinga 10h

AstraZeneca in talks over £300bn mega-merger with US rival – reports

Evening Standard 20h

AstraZeneca shares slump after $400bn BMS merger rumours

Pharmaceutical Technology 13h

Advertisement

Advertisement

Advertisement

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Nigeria (Naija) Nigeria Coronavirus (Covid-19)
- AstraZeneca